Complications in Central American Diabetic Patients: Historic Cohort

Insulin Degludec and Symptomatic Nocturnal Hypoglycaemia

NCT02192450 ·Status: COMPLETED ·Phase: PHASE4

Insulin Schemes for Type 2 Diabetes Control

NCT03350984 ·Status: COMPLETED ·Phase: PHASE4

Immunogenicity Safety Study of Wockhardt's Recombinant Insulin Analogue in Type 1 Diabetic Patients

NCT01352663 ·Status: WITHDRAWN ·Phase: PHASE3

A Study in Patients With Type 2 Diabetes Mellitus

NCT01435616 ·Status: COMPLETED ·Phase: PHASE3

Comparison of Insulin Detemir and NPH Insulin Given Once Daily in Ageing Subjects With Type 2 Diabetes

NCT00506662 ·Status: TERMINATED ·Phase: PHASE4

Observational Study Describing Conditions for Administering Slow-acting Insulin Analogue With Oral Antidiabetic Agents in Type 2 Diabetes on Blood Glucose Control

NCT00700960 ·Status: COMPLETED

A Comparison Between Glargine and Detemir Insulin in Type 2 Diabetes

NCT00457093 ·Status: COMPLETED ·Phase: NA

Switch From Premixed Human Insulin to Biphasic Insulin Aspart in the Netherlands

NCT01536626 ·Status: COMPLETED

A Study to Look at How Safe NNC0472-0147 is in Healthy People and in People With Type 2 Diabetes

NCT04262661 ·Status: COMPLETED ·Phase: PHASE1

Insulin Glulisine in Diabetes Mellitus, Type 2

NCT00174668 ·Status: COMPLETED ·Phase: PHASE3

Simplification of Complex Insulin Regimens With Preserving Good Glycemic Control in Type 2 Diabetes

NCT04020445 ·Status: COMPLETED

Risk of Hypoglycemia in Type 2 Diabetes

NCT00734669 ·Status: COMPLETED

Extension Study to Assess Safety and Efficacy of Mylan's Insulin Glargine and Lantus® in Type 1 Diabetes Mellitus (T1DM) Patients

NCT02666430 ·Status: COMPLETED ·Phase: PHASE3

A Research Study of How Overdosing of a New Once Weekly Medicine NNC0148-0287 C (Insulin 287) Influences the Blood Sugar Level in People With Type 2 Diabetes

NCT03945656 ·Status: COMPLETED ·Phase: PHASE1

Evaluation of Glycemic Control in Adults With Type 1 Diabetes When Switching to Insulin Degludec

NCT05434559 ·Status: COMPLETED

Glycaemic Control and Other Clinical Parameters in Adult Type 2 Diabetes Patients on Basal Insulin Initiating Treatment With IDegLira in Routine Clinical Practice in Colombia

NCT05324462 ·Status: COMPLETED

Comparison of Insulin Detemir Morning, Insulin Detemir Evening and NPH Insulin Evening in Patients With Type 2 Diabetes

NCT00104182 ·Status: COMPLETED ·Phase: PHASE3

Comparison of Two Insulin Detemir Formulations in Healthy Volunteers

NCT01498926 ·Status: COMPLETED ·Phase: PHASE1

Observational Study Evaluating the Safety of NovoMix® in Type 2 Diabetes Patients Previously Treated With a Human Premix Insulin

NCT00775736 ·Status: COMPLETED

Glycemic Effects of Morning Only, Evening Only or Twice Daily Insulin Glargine in Patients With Type 1 Diabetes

NCT00869414 ·Status: TERMINATED ·Phase: NA

Liraglutide or Insulin in Real Life Usage in Patients With Diabetes Mellitus Type 2

NCT01484262 ·Status: COMPLETED

Insulin Glargine Plus Insulin Glulisine Multiple Daily Injections (MDI) Versus Premix Insulin Treatment in Subjects With Diabetes Mellitus (Type 1 or Type 2)

NCT00135941 ·Status: COMPLETED ·Phase: PHASE3

Observational Study on Blood Glucose Control in Patients With Diabetes Using Modern Insulin

NCT00670722 ·Status: COMPLETED

Evaluation of Low Blood Sugar Events in Participants With Diabetes (MK-0431-402)

NCT01278485 ·Status: COMPLETED

A Study of All-Cause and Cardiovascular Mortality in Type 2 Diabetes Patients Using Basal Insulin Detemir and Glargine

NCT03960814 ·Status: COMPLETED